nodes	percent_of_prediction	percent_of_DWPC	metapath
Boceprevir—CYP3A4—Rivastigmine—Alzheimer's disease	0.081	0.432	CbGbCtD
Boceprevir—CYP3A4—Donepezil—Alzheimer's disease	0.0648	0.345	CbGbCtD
Boceprevir—CYP3A4—Galantamine—Alzheimer's disease	0.0417	0.223	CbGbCtD
Boceprevir—CMA1—blood vessel—Alzheimer's disease	0.0152	0.149	CbGeAlD
Boceprevir—CTSL—embryo—Alzheimer's disease	0.00774	0.076	CbGeAlD
Boceprevir—CTSL—forebrain—Alzheimer's disease	0.00684	0.0672	CbGeAlD
Boceprevir—CTSL—telencephalon—Alzheimer's disease	0.00629	0.0618	CbGeAlD
Boceprevir—CTSS—embryo—Alzheimer's disease	0.00511	0.0502	CbGeAlD
Boceprevir—CTSV—nervous system—Alzheimer's disease	0.00455	0.0447	CbGeAlD
Boceprevir—CTSS—forebrain—Alzheimer's disease	0.00452	0.0444	CbGeAlD
Boceprevir—CTSV—central nervous system—Alzheimer's disease	0.00438	0.043	CbGeAlD
Boceprevir—CTSS—telencephalon—Alzheimer's disease	0.00415	0.0408	CbGeAlD
Boceprevir—CTSL—nervous system—Alzheimer's disease	0.00372	0.0365	CbGeAlD
Boceprevir—CTSL—central nervous system—Alzheimer's disease	0.00358	0.0351	CbGeAlD
Boceprevir—CTSL—cerebellum—Alzheimer's disease	0.0035	0.0343	CbGeAlD
Boceprevir—CTSV—brain—Alzheimer's disease	0.00348	0.0341	CbGeAlD
Boceprevir—CTSL—brain—Alzheimer's disease	0.00284	0.0279	CbGeAlD
Boceprevir—CTSK—nervous system—Alzheimer's disease	0.0028	0.0275	CbGeAlD
Boceprevir—CTSK—central nervous system—Alzheimer's disease	0.0027	0.0265	CbGeAlD
Boceprevir—CTSK—cerebellum—Alzheimer's disease	0.00263	0.0259	CbGeAlD
Boceprevir—CTSS—nervous system—Alzheimer's disease	0.00245	0.0241	CbGeAlD
Boceprevir—CTSS—central nervous system—Alzheimer's disease	0.00236	0.0232	CbGeAlD
Boceprevir—CTSS—cerebellum—Alzheimer's disease	0.00231	0.0227	CbGeAlD
Boceprevir—CTSK—brain—Alzheimer's disease	0.00214	0.021	CbGeAlD
Boceprevir—CTSS—brain—Alzheimer's disease	0.00187	0.0184	CbGeAlD
Boceprevir—ABCB1—blood vessel—Alzheimer's disease	0.00151	0.0148	CbGeAlD
Boceprevir—ABCB1—embryo—Alzheimer's disease	0.000901	0.00885	CbGeAlD
Boceprevir—ABCB1—forebrain—Alzheimer's disease	0.000797	0.00783	CbGeAlD
Boceprevir—ABCB1—telencephalon—Alzheimer's disease	0.000733	0.0072	CbGeAlD
Boceprevir—CYP3A4—nervous system—Alzheimer's disease	0.000611	0.006	CbGeAlD
Boceprevir—CYP3A4—central nervous system—Alzheimer's disease	0.000589	0.00578	CbGeAlD
Boceprevir—Anxiety—Galantamine—Alzheimer's disease	0.000491	0.00115	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00049	0.00114	CcSEcCtD
Boceprevir—Sinusitis—Memantine—Alzheimer's disease	0.000489	0.00114	CcSEcCtD
Boceprevir—Discomfort—Galantamine—Alzheimer's disease	0.000487	0.00114	CcSEcCtD
Boceprevir—Agranulocytosis—Memantine—Alzheimer's disease	0.000487	0.00114	CcSEcCtD
Boceprevir—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000482	0.00113	CcSEcCtD
Boceprevir—Dry mouth—Galantamine—Alzheimer's disease	0.000482	0.00113	CcSEcCtD
Boceprevir—Epistaxis—Rivastigmine—Alzheimer's disease	0.000481	0.00112	CcSEcCtD
Boceprevir—Tinnitus—Donepezil—Alzheimer's disease	0.000481	0.00112	CcSEcCtD
Boceprevir—Sinusitis—Rivastigmine—Alzheimer's disease	0.000479	0.00112	CcSEcCtD
Boceprevir—Confusional state—Galantamine—Alzheimer's disease	0.000477	0.00111	CcSEcCtD
Boceprevir—Rhinitis—Memantine—Alzheimer's disease	0.000469	0.0011	CcSEcCtD
Boceprevir—Hypoaesthesia—Memantine—Alzheimer's disease	0.000466	0.00109	CcSEcCtD
Boceprevir—Shock—Galantamine—Alzheimer's disease	0.000465	0.00109	CcSEcCtD
Boceprevir—Pharyngitis—Memantine—Alzheimer's disease	0.000465	0.00109	CcSEcCtD
Boceprevir—Nervous system disorder—Galantamine—Alzheimer's disease	0.000464	0.00108	CcSEcCtD
Boceprevir—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000463	0.00108	CcSEcCtD
Boceprevir—Chills—Donepezil—Alzheimer's disease	0.000463	0.00108	CcSEcCtD
Boceprevir—Urinary tract disorder—Memantine—Alzheimer's disease	0.000462	0.00108	CcSEcCtD
Boceprevir—Tachycardia—Galantamine—Alzheimer's disease	0.000461	0.00108	CcSEcCtD
Boceprevir—Oedema peripheral—Memantine—Alzheimer's disease	0.000461	0.00108	CcSEcCtD
Boceprevir—Arrhythmia—Donepezil—Alzheimer's disease	0.000461	0.00108	CcSEcCtD
Boceprevir—Connective tissue disorder—Memantine—Alzheimer's disease	0.00046	0.00107	CcSEcCtD
Boceprevir—Rhinitis—Rivastigmine—Alzheimer's disease	0.000459	0.00107	CcSEcCtD
Boceprevir—Skin disorder—Galantamine—Alzheimer's disease	0.000459	0.00107	CcSEcCtD
Boceprevir—Urethral disorder—Memantine—Alzheimer's disease	0.000459	0.00107	CcSEcCtD
Boceprevir—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000457	0.00107	CcSEcCtD
Boceprevir—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000456	0.00106	CcSEcCtD
Boceprevir—Alopecia—Donepezil—Alzheimer's disease	0.000456	0.00106	CcSEcCtD
Boceprevir—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000455	0.00106	CcSEcCtD
Boceprevir—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000452	0.00106	CcSEcCtD
Boceprevir—Mental disorder—Donepezil—Alzheimer's disease	0.000452	0.00106	CcSEcCtD
Boceprevir—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000451	0.00105	CcSEcCtD
Boceprevir—Visual impairment—Memantine—Alzheimer's disease	0.000451	0.00105	CcSEcCtD
Boceprevir—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00045	0.00105	CcSEcCtD
Boceprevir—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000449	0.00105	CcSEcCtD
Boceprevir—Erythema—Donepezil—Alzheimer's disease	0.000449	0.00105	CcSEcCtD
Boceprevir—Malnutrition—Donepezil—Alzheimer's disease	0.000449	0.00105	CcSEcCtD
Boceprevir—Erythema multiforme—Memantine—Alzheimer's disease	0.000443	0.00103	CcSEcCtD
Boceprevir—Flatulence—Donepezil—Alzheimer's disease	0.000442	0.00103	CcSEcCtD
Boceprevir—Hypotension—Galantamine—Alzheimer's disease	0.000442	0.00103	CcSEcCtD
Boceprevir—Visual impairment—Rivastigmine—Alzheimer's disease	0.000441	0.00103	CcSEcCtD
Boceprevir—Dysgeusia—Donepezil—Alzheimer's disease	0.00044	0.00103	CcSEcCtD
Boceprevir—Eye disorder—Memantine—Alzheimer's disease	0.000437	0.00102	CcSEcCtD
Boceprevir—Tinnitus—Memantine—Alzheimer's disease	0.000436	0.00102	CcSEcCtD
Boceprevir—Cardiac disorder—Memantine—Alzheimer's disease	0.000434	0.00101	CcSEcCtD
Boceprevir—Flushing—Memantine—Alzheimer's disease	0.000434	0.00101	CcSEcCtD
Boceprevir—Back pain—Donepezil—Alzheimer's disease	0.000434	0.00101	CcSEcCtD
Boceprevir—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000433	0.00101	CcSEcCtD
Boceprevir—ABCB1—nervous system—Alzheimer's disease	0.000433	0.00425	CbGeAlD
Boceprevir—Muscle spasms—Donepezil—Alzheimer's disease	0.000432	0.00101	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000431	0.00101	CcSEcCtD
Boceprevir—Eye disorder—Rivastigmine—Alzheimer's disease	0.000428	0.001	CcSEcCtD
Boceprevir—Insomnia—Galantamine—Alzheimer's disease	0.000427	0.000999	CcSEcCtD
Boceprevir—Tinnitus—Rivastigmine—Alzheimer's disease	0.000427	0.000997	CcSEcCtD
Boceprevir—Flushing—Rivastigmine—Alzheimer's disease	0.000425	0.000993	CcSEcCtD
Boceprevir—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000425	0.000993	CcSEcCtD
Boceprevir—Angiopathy—Memantine—Alzheimer's disease	0.000425	0.000992	CcSEcCtD
Boceprevir—Paraesthesia—Galantamine—Alzheimer's disease	0.000424	0.000991	CcSEcCtD
Boceprevir—Vision blurred—Donepezil—Alzheimer's disease	0.000423	0.000988	CcSEcCtD
Boceprevir—Immune system disorder—Memantine—Alzheimer's disease	0.000423	0.000988	CcSEcCtD
Boceprevir—Mediastinal disorder—Memantine—Alzheimer's disease	0.000422	0.000986	CcSEcCtD
Boceprevir—Chills—Memantine—Alzheimer's disease	0.00042	0.000981	CcSEcCtD
Boceprevir—Arrhythmia—Memantine—Alzheimer's disease	0.000418	0.000977	CcSEcCtD
Boceprevir—ABCB1—central nervous system—Alzheimer's disease	0.000417	0.00409	CbGeAlD
Boceprevir—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000416	0.000973	CcSEcCtD
Boceprevir—Dyspepsia—Galantamine—Alzheimer's disease	0.000416	0.000972	CcSEcCtD
Boceprevir—Angiopathy—Rivastigmine—Alzheimer's disease	0.000415	0.000971	CcSEcCtD
Boceprevir—Anaemia—Donepezil—Alzheimer's disease	0.000415	0.000969	CcSEcCtD
Boceprevir—Alopecia—Memantine—Alzheimer's disease	0.000414	0.000966	CcSEcCtD
Boceprevir—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000413	0.000964	CcSEcCtD
Boceprevir—Agitation—Donepezil—Alzheimer's disease	0.000412	0.000963	CcSEcCtD
Boceprevir—Chills—Rivastigmine—Alzheimer's disease	0.000411	0.00096	CcSEcCtD
Boceprevir—Decreased appetite—Galantamine—Alzheimer's disease	0.000411	0.00096	CcSEcCtD
Boceprevir—Mental disorder—Memantine—Alzheimer's disease	0.00041	0.000958	CcSEcCtD
Boceprevir—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000409	0.000956	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000408	0.000953	CcSEcCtD
Boceprevir—Malnutrition—Memantine—Alzheimer's disease	0.000408	0.000952	CcSEcCtD
Boceprevir—Fatigue—Galantamine—Alzheimer's disease	0.000407	0.000952	CcSEcCtD
Boceprevir—ABCB1—cerebellum—Alzheimer's disease	0.000407	0.004	CbGeAlD
Boceprevir—Malaise—Donepezil—Alzheimer's disease	0.000405	0.000945	CcSEcCtD
Boceprevir—Alopecia—Rivastigmine—Alzheimer's disease	0.000405	0.000945	CcSEcCtD
Boceprevir—Constipation—Galantamine—Alzheimer's disease	0.000404	0.000944	CcSEcCtD
Boceprevir—Vertigo—Donepezil—Alzheimer's disease	0.000403	0.000942	CcSEcCtD
Boceprevir—Syncope—Donepezil—Alzheimer's disease	0.000402	0.00094	CcSEcCtD
Boceprevir—Flatulence—Memantine—Alzheimer's disease	0.000402	0.000938	CcSEcCtD
Boceprevir—Mental disorder—Rivastigmine—Alzheimer's disease	0.000401	0.000937	CcSEcCtD
Boceprevir—Dysgeusia—Memantine—Alzheimer's disease	0.000399	0.000932	CcSEcCtD
Boceprevir—Malnutrition—Rivastigmine—Alzheimer's disease	0.000399	0.000931	CcSEcCtD
Boceprevir—Erythema—Rivastigmine—Alzheimer's disease	0.000399	0.000931	CcSEcCtD
Boceprevir—Loss of consciousness—Donepezil—Alzheimer's disease	0.000394	0.000921	CcSEcCtD
Boceprevir—Back pain—Memantine—Alzheimer's disease	0.000394	0.000921	CcSEcCtD
Boceprevir—Flatulence—Rivastigmine—Alzheimer's disease	0.000393	0.000918	CcSEcCtD
Boceprevir—Cough—Donepezil—Alzheimer's disease	0.000392	0.000915	CcSEcCtD
Boceprevir—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00039	0.000912	CcSEcCtD
Boceprevir—Feeling abnormal—Galantamine—Alzheimer's disease	0.000389	0.00091	CcSEcCtD
Boceprevir—Hypertension—Donepezil—Alzheimer's disease	0.000387	0.000905	CcSEcCtD
Boceprevir—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000386	0.000903	CcSEcCtD
Boceprevir—Back pain—Rivastigmine—Alzheimer's disease	0.000386	0.000901	CcSEcCtD
Boceprevir—Vision blurred—Memantine—Alzheimer's disease	0.000384	0.000897	CcSEcCtD
Boceprevir—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000383	0.000895	CcSEcCtD
Boceprevir—Chest pain—Donepezil—Alzheimer's disease	0.000382	0.000893	CcSEcCtD
Boceprevir—Arthralgia—Donepezil—Alzheimer's disease	0.000382	0.000893	CcSEcCtD
Boceprevir—Myalgia—Donepezil—Alzheimer's disease	0.000382	0.000893	CcSEcCtD
Boceprevir—Anxiety—Donepezil—Alzheimer's disease	0.000381	0.000889	CcSEcCtD
Boceprevir—Ill-defined disorder—Memantine—Alzheimer's disease	0.000378	0.000883	CcSEcCtD
Boceprevir—Discomfort—Donepezil—Alzheimer's disease	0.000378	0.000882	CcSEcCtD
Boceprevir—Anaemia—Memantine—Alzheimer's disease	0.000377	0.00088	CcSEcCtD
Boceprevir—Vision blurred—Rivastigmine—Alzheimer's disease	0.000376	0.000878	CcSEcCtD
Boceprevir—Agitation—Memantine—Alzheimer's disease	0.000374	0.000875	CcSEcCtD
Boceprevir—Dry mouth—Donepezil—Alzheimer's disease	0.000374	0.000873	CcSEcCtD
Boceprevir—Abdominal pain—Galantamine—Alzheimer's disease	0.000374	0.000873	CcSEcCtD
Boceprevir—Body temperature increased—Galantamine—Alzheimer's disease	0.000374	0.000873	CcSEcCtD
Boceprevir—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00037	0.000864	CcSEcCtD
Boceprevir—Confusional state—Donepezil—Alzheimer's disease	0.000369	0.000863	CcSEcCtD
Boceprevir—Anaemia—Rivastigmine—Alzheimer's disease	0.000368	0.000861	CcSEcCtD
Boceprevir—Malaise—Memantine—Alzheimer's disease	0.000367	0.000858	CcSEcCtD
Boceprevir—Agitation—Rivastigmine—Alzheimer's disease	0.000366	0.000856	CcSEcCtD
Boceprevir—Vertigo—Memantine—Alzheimer's disease	0.000366	0.000855	CcSEcCtD
Boceprevir—Syncope—Memantine—Alzheimer's disease	0.000365	0.000854	CcSEcCtD
Boceprevir—Leukopenia—Memantine—Alzheimer's disease	0.000365	0.000852	CcSEcCtD
Boceprevir—Infection—Donepezil—Alzheimer's disease	0.000364	0.00085	CcSEcCtD
Boceprevir—Shock—Donepezil—Alzheimer's disease	0.00036	0.000842	CcSEcCtD
Boceprevir—Palpitations—Memantine—Alzheimer's disease	0.00036	0.000841	CcSEcCtD
Boceprevir—Malaise—Rivastigmine—Alzheimer's disease	0.00036	0.00084	CcSEcCtD
Boceprevir—Nervous system disorder—Donepezil—Alzheimer's disease	0.000359	0.000839	CcSEcCtD
Boceprevir—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000359	0.000838	CcSEcCtD
Boceprevir—Vertigo—Rivastigmine—Alzheimer's disease	0.000358	0.000837	CcSEcCtD
Boceprevir—Loss of consciousness—Memantine—Alzheimer's disease	0.000358	0.000837	CcSEcCtD
Boceprevir—Syncope—Rivastigmine—Alzheimer's disease	0.000358	0.000835	CcSEcCtD
Boceprevir—Cough—Memantine—Alzheimer's disease	0.000356	0.000831	CcSEcCtD
Boceprevir—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000354	0.000827	CcSEcCtD
Boceprevir—Palpitations—Rivastigmine—Alzheimer's disease	0.000352	0.000823	CcSEcCtD
Boceprevir—Hypertension—Memantine—Alzheimer's disease	0.000352	0.000822	CcSEcCtD
Boceprevir—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00035	0.000818	CcSEcCtD
Boceprevir—Hypersensitivity—Galantamine—Alzheimer's disease	0.000348	0.000813	CcSEcCtD
Boceprevir—Cough—Rivastigmine—Alzheimer's disease	0.000348	0.000813	CcSEcCtD
Boceprevir—Arthralgia—Memantine—Alzheimer's disease	0.000347	0.00081	CcSEcCtD
Boceprevir—Myalgia—Memantine—Alzheimer's disease	0.000347	0.00081	CcSEcCtD
Boceprevir—Chest pain—Memantine—Alzheimer's disease	0.000347	0.00081	CcSEcCtD
Boceprevir—Anxiety—Memantine—Alzheimer's disease	0.000346	0.000808	CcSEcCtD
Boceprevir—Hypertension—Rivastigmine—Alzheimer's disease	0.000344	0.000804	CcSEcCtD
Boceprevir—Discomfort—Memantine—Alzheimer's disease	0.000343	0.000801	CcSEcCtD
Boceprevir—Hypotension—Donepezil—Alzheimer's disease	0.000342	0.0008	CcSEcCtD
Boceprevir—Myalgia—Rivastigmine—Alzheimer's disease	0.000339	0.000793	CcSEcCtD
Boceprevir—Arthralgia—Rivastigmine—Alzheimer's disease	0.000339	0.000793	CcSEcCtD
Boceprevir—Chest pain—Rivastigmine—Alzheimer's disease	0.000339	0.000793	CcSEcCtD
Boceprevir—Dry mouth—Memantine—Alzheimer's disease	0.000339	0.000793	CcSEcCtD
Boceprevir—Asthenia—Galantamine—Alzheimer's disease	0.000339	0.000792	CcSEcCtD
Boceprevir—Anxiety—Rivastigmine—Alzheimer's disease	0.000338	0.00079	CcSEcCtD
Boceprevir—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000337	0.000787	CcSEcCtD
Boceprevir—Confusional state—Memantine—Alzheimer's disease	0.000335	0.000783	CcSEcCtD
Boceprevir—Discomfort—Rivastigmine—Alzheimer's disease	0.000335	0.000783	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000334	0.00078	CcSEcCtD
Boceprevir—Dry mouth—Rivastigmine—Alzheimer's disease	0.000332	0.000775	CcSEcCtD
Boceprevir—Insomnia—Donepezil—Alzheimer's disease	0.000331	0.000774	CcSEcCtD
Boceprevir—ABCB1—brain—Alzheimer's disease	0.000331	0.00325	CbGeAlD
Boceprevir—Infection—Memantine—Alzheimer's disease	0.00033	0.000772	CcSEcCtD
Boceprevir—Paraesthesia—Donepezil—Alzheimer's disease	0.000329	0.000768	CcSEcCtD
Boceprevir—Confusional state—Rivastigmine—Alzheimer's disease	0.000328	0.000766	CcSEcCtD
Boceprevir—Shock—Memantine—Alzheimer's disease	0.000327	0.000764	CcSEcCtD
Boceprevir—Dyspnoea—Donepezil—Alzheimer's disease	0.000327	0.000763	CcSEcCtD
Boceprevir—Nervous system disorder—Memantine—Alzheimer's disease	0.000326	0.000762	CcSEcCtD
Boceprevir—Thrombocytopenia—Memantine—Alzheimer's disease	0.000326	0.000761	CcSEcCtD
Boceprevir—Tachycardia—Memantine—Alzheimer's disease	0.000325	0.000758	CcSEcCtD
Boceprevir—Diarrhoea—Galantamine—Alzheimer's disease	0.000323	0.000755	CcSEcCtD
Boceprevir—Infection—Rivastigmine—Alzheimer's disease	0.000323	0.000755	CcSEcCtD
Boceprevir—Skin disorder—Memantine—Alzheimer's disease	0.000323	0.000755	CcSEcCtD
Boceprevir—Dyspepsia—Donepezil—Alzheimer's disease	0.000322	0.000753	CcSEcCtD
Boceprevir—Hyperhidrosis—Memantine—Alzheimer's disease	0.000322	0.000751	CcSEcCtD
Boceprevir—Shock—Rivastigmine—Alzheimer's disease	0.00032	0.000748	CcSEcCtD
Boceprevir—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000319	0.000745	CcSEcCtD
Boceprevir—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000319	0.000744	CcSEcCtD
Boceprevir—Decreased appetite—Donepezil—Alzheimer's disease	0.000318	0.000744	CcSEcCtD
Boceprevir—Tachycardia—Rivastigmine—Alzheimer's disease	0.000318	0.000742	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000316	0.000739	CcSEcCtD
Boceprevir—Skin disorder—Rivastigmine—Alzheimer's disease	0.000316	0.000738	CcSEcCtD
Boceprevir—Fatigue—Donepezil—Alzheimer's disease	0.000316	0.000738	CcSEcCtD
Boceprevir—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000315	0.000735	CcSEcCtD
Boceprevir—Constipation—Donepezil—Alzheimer's disease	0.000313	0.000732	CcSEcCtD
Boceprevir—Pain—Donepezil—Alzheimer's disease	0.000313	0.000732	CcSEcCtD
Boceprevir—Dizziness—Galantamine—Alzheimer's disease	0.000313	0.00073	CcSEcCtD
Boceprevir—Hypotension—Memantine—Alzheimer's disease	0.000311	0.000726	CcSEcCtD
Boceprevir—Hypotension—Rivastigmine—Alzheimer's disease	0.000304	0.00071	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000303	0.000708	CcSEcCtD
Boceprevir—Feeling abnormal—Donepezil—Alzheimer's disease	0.000302	0.000705	CcSEcCtD
Boceprevir—Insomnia—Memantine—Alzheimer's disease	0.000301	0.000703	CcSEcCtD
Boceprevir—Vomiting—Galantamine—Alzheimer's disease	0.000301	0.000702	CcSEcCtD
Boceprevir—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.0003	0.0007	CcSEcCtD
Boceprevir—Paraesthesia—Memantine—Alzheimer's disease	0.000299	0.000698	CcSEcCtD
Boceprevir—Rash—Galantamine—Alzheimer's disease	0.000298	0.000696	CcSEcCtD
Boceprevir—Dermatitis—Galantamine—Alzheimer's disease	0.000298	0.000695	CcSEcCtD
Boceprevir—Dyspnoea—Memantine—Alzheimer's disease	0.000297	0.000693	CcSEcCtD
Boceprevir—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000296	0.000692	CcSEcCtD
Boceprevir—Headache—Galantamine—Alzheimer's disease	0.000296	0.000692	CcSEcCtD
Boceprevir—Insomnia—Rivastigmine—Alzheimer's disease	0.000294	0.000687	CcSEcCtD
Boceprevir—Dyspepsia—Memantine—Alzheimer's disease	0.000293	0.000684	CcSEcCtD
Boceprevir—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000292	0.000682	CcSEcCtD
Boceprevir—Urticaria—Donepezil—Alzheimer's disease	0.000291	0.00068	CcSEcCtD
Boceprevir—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00029	0.000678	CcSEcCtD
Boceprevir—Abdominal pain—Donepezil—Alzheimer's disease	0.00029	0.000676	CcSEcCtD
Boceprevir—Body temperature increased—Donepezil—Alzheimer's disease	0.00029	0.000676	CcSEcCtD
Boceprevir—Decreased appetite—Memantine—Alzheimer's disease	0.000289	0.000675	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000287	0.000671	CcSEcCtD
Boceprevir—Fatigue—Memantine—Alzheimer's disease	0.000287	0.00067	CcSEcCtD
Boceprevir—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000286	0.000669	CcSEcCtD
Boceprevir—Pain—Memantine—Alzheimer's disease	0.000284	0.000664	CcSEcCtD
Boceprevir—Constipation—Memantine—Alzheimer's disease	0.000284	0.000664	CcSEcCtD
Boceprevir—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000283	0.000661	CcSEcCtD
Boceprevir—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000281	0.000656	CcSEcCtD
Boceprevir—Nausea—Galantamine—Alzheimer's disease	0.000281	0.000656	CcSEcCtD
Boceprevir—Fatigue—Rivastigmine—Alzheimer's disease	0.000281	0.000655	CcSEcCtD
Boceprevir—Pain—Rivastigmine—Alzheimer's disease	0.000278	0.00065	CcSEcCtD
Boceprevir—Constipation—Rivastigmine—Alzheimer's disease	0.000278	0.00065	CcSEcCtD
Boceprevir—Feeling abnormal—Memantine—Alzheimer's disease	0.000274	0.00064	CcSEcCtD
Boceprevir—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000272	0.000635	CcSEcCtD
Boceprevir—Hypersensitivity—Donepezil—Alzheimer's disease	0.00027	0.00063	CcSEcCtD
Boceprevir—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000268	0.000626	CcSEcCtD
Boceprevir—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000266	0.000621	CcSEcCtD
Boceprevir—Urticaria—Memantine—Alzheimer's disease	0.000264	0.000617	CcSEcCtD
Boceprevir—Abdominal pain—Memantine—Alzheimer's disease	0.000263	0.000614	CcSEcCtD
Boceprevir—Body temperature increased—Memantine—Alzheimer's disease	0.000263	0.000614	CcSEcCtD
Boceprevir—Asthenia—Donepezil—Alzheimer's disease	0.000263	0.000614	CcSEcCtD
Boceprevir—Pruritus—Donepezil—Alzheimer's disease	0.000259	0.000605	CcSEcCtD
Boceprevir—Urticaria—Rivastigmine—Alzheimer's disease	0.000258	0.000604	CcSEcCtD
Boceprevir—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000257	0.000601	CcSEcCtD
Boceprevir—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000257	0.000601	CcSEcCtD
Boceprevir—Diarrhoea—Donepezil—Alzheimer's disease	0.000251	0.000585	CcSEcCtD
Boceprevir—Hypersensitivity—Memantine—Alzheimer's disease	0.000245	0.000572	CcSEcCtD
Boceprevir—Dizziness—Donepezil—Alzheimer's disease	0.000242	0.000566	CcSEcCtD
Boceprevir—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00024	0.00056	CcSEcCtD
Boceprevir—Asthenia—Memantine—Alzheimer's disease	0.000239	0.000557	CcSEcCtD
Boceprevir—Pruritus—Memantine—Alzheimer's disease	0.000235	0.00055	CcSEcCtD
Boceprevir—Asthenia—Rivastigmine—Alzheimer's disease	0.000233	0.000545	CcSEcCtD
Boceprevir—Vomiting—Donepezil—Alzheimer's disease	0.000233	0.000544	CcSEcCtD
Boceprevir—Rash—Donepezil—Alzheimer's disease	0.000231	0.000539	CcSEcCtD
Boceprevir—Dermatitis—Donepezil—Alzheimer's disease	0.000231	0.000539	CcSEcCtD
Boceprevir—Pruritus—Rivastigmine—Alzheimer's disease	0.00023	0.000538	CcSEcCtD
Boceprevir—Headache—Donepezil—Alzheimer's disease	0.000229	0.000536	CcSEcCtD
Boceprevir—Diarrhoea—Memantine—Alzheimer's disease	0.000228	0.000532	CcSEcCtD
Boceprevir—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000223	0.00052	CcSEcCtD
Boceprevir—Dizziness—Memantine—Alzheimer's disease	0.00022	0.000514	CcSEcCtD
Boceprevir—Nausea—Donepezil—Alzheimer's disease	0.000218	0.000508	CcSEcCtD
Boceprevir—Dizziness—Rivastigmine—Alzheimer's disease	0.000215	0.000503	CcSEcCtD
Boceprevir—Vomiting—Memantine—Alzheimer's disease	0.000211	0.000494	CcSEcCtD
Boceprevir—Rash—Memantine—Alzheimer's disease	0.00021	0.00049	CcSEcCtD
Boceprevir—Dermatitis—Memantine—Alzheimer's disease	0.00021	0.000489	CcSEcCtD
Boceprevir—Headache—Memantine—Alzheimer's disease	0.000208	0.000487	CcSEcCtD
Boceprevir—Vomiting—Rivastigmine—Alzheimer's disease	0.000207	0.000483	CcSEcCtD
Boceprevir—Rash—Rivastigmine—Alzheimer's disease	0.000205	0.000479	CcSEcCtD
Boceprevir—Dermatitis—Rivastigmine—Alzheimer's disease	0.000205	0.000479	CcSEcCtD
Boceprevir—Headache—Rivastigmine—Alzheimer's disease	0.000204	0.000476	CcSEcCtD
Boceprevir—Nausea—Memantine—Alzheimer's disease	0.000198	0.000461	CcSEcCtD
Boceprevir—Nausea—Rivastigmine—Alzheimer's disease	0.000193	0.000451	CcSEcCtD
Boceprevir—CMA1—Signaling Pathways—CRH—Alzheimer's disease	9.47e-05	0.000335	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CALM1—Alzheimer's disease	9.43e-05	0.000334	CbGpPWpGaD
Boceprevir—CTSK—Immune System—S100B—Alzheimer's disease	9.36e-05	0.000331	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	9.19e-05	0.000325	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—LEP—Alzheimer's disease	9.14e-05	0.000324	CbGpPWpGaD
Boceprevir—CTSS—Extracellular matrix organization—TGFB1—Alzheimer's disease	9.06e-05	0.000321	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	9.04e-05	0.00032	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NPS—Alzheimer's disease	8.98e-05	0.000318	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PPP3CA—Alzheimer's disease	8.94e-05	0.000316	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	8.81e-05	0.000312	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PTK2B—Alzheimer's disease	8.81e-05	0.000312	CbGpPWpGaD
Boceprevir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	8.64e-05	0.000306	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—BCL2—Alzheimer's disease	8.57e-05	0.000303	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NTRK2—Alzheimer's disease	8.57e-05	0.000303	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GAB2—Alzheimer's disease	8.57e-05	0.000303	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—SST—Alzheimer's disease	8.57e-05	0.000303	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—NOS2—Alzheimer's disease	8.52e-05	0.000302	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GSK3A—Alzheimer's disease	8.49e-05	0.000301	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—GSK3B—Alzheimer's disease	8.48e-05	0.0003	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1A—Alzheimer's disease	8.46e-05	0.0003	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—CREB1—Alzheimer's disease	8.41e-05	0.000298	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—MAPK8—Alzheimer's disease	8.39e-05	0.000297	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—MAPK8—Alzheimer's disease	8.39e-05	0.000297	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CALM1—Alzheimer's disease	8.39e-05	0.000297	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CALM1—Alzheimer's disease	8.39e-05	0.000297	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	8.36e-05	0.000296	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APP—Alzheimer's disease	8.35e-05	0.000295	CbGpPWpGaD
Boceprevir—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	8.34e-05	0.000295	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MEF2C—Alzheimer's disease	8.19e-05	0.00029	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—GSK3B—Alzheimer's disease	8.14e-05	0.000288	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	8.12e-05	0.000287	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AGER—Alzheimer's disease	8.11e-05	0.000287	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—CREB1—Alzheimer's disease	8.08e-05	0.000286	CbGpPWpGaD
Boceprevir—CTSK—Immune System—PRKCG—Alzheimer's disease	8.03e-05	0.000284	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PLCB1—Alzheimer's disease	7.88e-05	0.000279	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—CREB1—Alzheimer's disease	7.85e-05	0.000278	CbGpPWpGaD
Boceprevir—CTSS—Immune System—S100B—Alzheimer's disease	7.71e-05	0.000273	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	7.59e-05	0.000269	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	7.46e-05	0.000264	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NGFR—Alzheimer's disease	7.35e-05	0.00026	CbGpPWpGaD
Boceprevir—CTSL—Immune System—GSK3B—Alzheimer's disease	7.24e-05	0.000256	CbGpPWpGaD
Boceprevir—CTSV—Immune System—GSK3B—Alzheimer's disease	7.24e-05	0.000256	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ADAM10—Alzheimer's disease	7.18e-05	0.000254	CbGpPWpGaD
Boceprevir—CTSL—Immune System—CREB1—Alzheimer's disease	7.18e-05	0.000254	CbGpPWpGaD
Boceprevir—CTSV—Immune System—CREB1—Alzheimer's disease	7.18e-05	0.000254	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—BCL2—Alzheimer's disease	7.06e-05	0.00025	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1A—Alzheimer's disease	6.97e-05	0.000247	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—MAPK8—Alzheimer's disease	6.95e-05	0.000246	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CALM1—Alzheimer's disease	6.95e-05	0.000246	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—S100B—Alzheimer's disease	6.79e-05	0.00024	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MEF2C—Alzheimer's disease	6.74e-05	0.000239	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AGER—Alzheimer's disease	6.68e-05	0.000236	CbGpPWpGaD
Boceprevir—CTSS—Immune System—PRKCG—Alzheimer's disease	6.61e-05	0.000234	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	6.61e-05	0.000234	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	6.49e-05	0.00023	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF2—Alzheimer's disease	6.46e-05	0.000229	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	6.37e-05	0.000226	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF1R—Alzheimer's disease	6.25e-05	0.000221	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	6.18e-05	0.000219	CbGpPWpGaD
Boceprevir—CTSL—Immune System—BCL2—Alzheimer's disease	6.03e-05	0.000213	CbGpPWpGaD
Boceprevir—CTSV—Immune System—BCL2—Alzheimer's disease	6.03e-05	0.000213	CbGpPWpGaD
Boceprevir—CTSK—Immune System—GSK3B—Alzheimer's disease	6e-05	0.000212	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LPL—Alzheimer's disease	5.99e-05	0.000212	CbGpPWpGaD
Boceprevir—CTSK—Immune System—CREB1—Alzheimer's disease	5.95e-05	0.00021	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MEF2C—Alzheimer's disease	5.94e-05	0.00021	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—PRKCG—Alzheimer's disease	5.83e-05	0.000206	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—MAPK8—Alzheimer's disease	5.72e-05	0.000203	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CALM1—Alzheimer's disease	5.72e-05	0.000202	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—DHCR24—Alzheimer's disease	5.71e-05	0.000202	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NGF—Alzheimer's disease	5.67e-05	0.000201	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCR5—Alzheimer's disease	5.52e-05	0.000195	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	5.42e-05	0.000192	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—HTR2A—Alzheimer's disease	5.4e-05	0.000191	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—IL6—Alzheimer's disease	5.36e-05	0.00019	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—IL6—Alzheimer's disease	5.36e-05	0.00019	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL1B—Alzheimer's disease	5.33e-05	0.000189	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL1B—Alzheimer's disease	5.33e-05	0.000189	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	5.05e-05	0.000179	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CALM1—Alzheimer's disease	5.04e-05	0.000178	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	5.04e-05	0.000178	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—LEP—Alzheimer's disease	5.02e-05	0.000178	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—APOE—Alzheimer's disease	5.02e-05	0.000178	CbGpPWpGaD
Boceprevir—CTSK—Immune System—BCL2—Alzheimer's disease	4.99e-05	0.000177	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CAV1—Alzheimer's disease	4.98e-05	0.000176	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	4.97e-05	0.000176	CbGpPWpGaD
Boceprevir—CTSV—Innate Immune System—AKT1—Alzheimer's disease	4.94e-05	0.000175	CbGpPWpGaD
Boceprevir—CTSL—Innate Immune System—AKT1—Alzheimer's disease	4.94e-05	0.000175	CbGpPWpGaD
Boceprevir—CTSS—Immune System—GSK3B—Alzheimer's disease	4.94e-05	0.000175	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	4.93e-05	0.000175	CbGpPWpGaD
Boceprevir—CTSS—Immune System—CREB1—Alzheimer's disease	4.9e-05	0.000173	CbGpPWpGaD
Boceprevir—CTSL—Immune System—MAPK8—Alzheimer's disease	4.88e-05	0.000173	CbGpPWpGaD
Boceprevir—CTSV—Immune System—MAPK8—Alzheimer's disease	4.88e-05	0.000173	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CA4—Alzheimer's disease	4.85e-05	0.000172	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—ESR1—Alzheimer's disease	4.79e-05	0.00017	CbGpPWpGaD
Boceprevir—CTSL—Adaptive Immune System—AKT1—Alzheimer's disease	4.74e-05	0.000168	CbGpPWpGaD
Boceprevir—CTSV—Adaptive Immune System—AKT1—Alzheimer's disease	4.74e-05	0.000168	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—F2—Alzheimer's disease	4.74e-05	0.000168	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	4.68e-05	0.000166	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.63e-05	0.000164	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	4.63e-05	0.000164	CbGpPWpGaD
Boceprevir—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	4.59e-05	0.000162	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GAPDHS—Alzheimer's disease	4.56e-05	0.000161	CbGpPWpGaD
Boceprevir—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	4.53e-05	0.00016	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—IL6—Alzheimer's disease	4.44e-05	0.000157	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL1B—Alzheimer's disease	4.41e-05	0.000156	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—GSK3B—Alzheimer's disease	4.35e-05	0.000154	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ATP5A1—Alzheimer's disease	4.32e-05	0.000153	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CREB1—Alzheimer's disease	4.31e-05	0.000153	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—DHCR24—Alzheimer's disease	4.31e-05	0.000152	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—INS—Alzheimer's disease	4.29e-05	0.000152	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	4.27e-05	0.000151	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CCL2—Alzheimer's disease	4.22e-05	0.000149	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IGF1—Alzheimer's disease	4.15e-05	0.000147	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLD3—Alzheimer's disease	4.13e-05	0.000146	CbGpPWpGaD
Boceprevir—CTSS—Immune System—BCL2—Alzheimer's disease	4.11e-05	0.000146	CbGpPWpGaD
Boceprevir—CTSK—Innate Immune System—AKT1—Alzheimer's disease	4.09e-05	0.000145	CbGpPWpGaD
Boceprevir—CTSK—Immune System—MAPK8—Alzheimer's disease	4.05e-05	0.000143	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HSD17B10—Alzheimer's disease	3.96e-05	0.00014	CbGpPWpGaD
Boceprevir—CTSK—Adaptive Immune System—AKT1—Alzheimer's disease	3.93e-05	0.000139	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	3.92e-05	0.000139	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP46A1—Alzheimer's disease	3.81e-05	0.000135	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—NOS3—Alzheimer's disease	3.76e-05	0.000133	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	3.73e-05	0.000132	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ND1—Alzheimer's disease	3.68e-05	0.00013	CbGpPWpGaD
Boceprevir—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	3.66e-05	0.00013	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CA4—Alzheimer's disease	3.66e-05	0.00013	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—IL6—Alzheimer's disease	3.65e-05	0.000129	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL1B—Alzheimer's disease	3.63e-05	0.000129	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	3.44e-05	0.000122	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	3.4e-05	0.00012	CbGpPWpGaD
Boceprevir—CTSS—Innate Immune System—AKT1—Alzheimer's disease	3.37e-05	0.000119	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	3.36e-05	0.000119	CbGpPWpGaD
Boceprevir—CTSS—Immune System—MAPK8—Alzheimer's disease	3.33e-05	0.000118	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	3.26e-05	0.000115	CbGpPWpGaD
Boceprevir—CTSS—Adaptive Immune System—AKT1—Alzheimer's disease	3.24e-05	0.000115	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	3.23e-05	0.000114	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—CASP3—Alzheimer's disease	3.19e-05	0.000113	CbGpPWpGaD
Boceprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	3.15e-05	0.000111	CbGpPWpGaD
Boceprevir—CTSL—Immune System—IL6—Alzheimer's disease	3.12e-05	0.00011	CbGpPWpGaD
Boceprevir—CTSV—Immune System—IL6—Alzheimer's disease	3.12e-05	0.00011	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLD3—Alzheimer's disease	3.11e-05	0.00011	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	2.98e-05	0.000106	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—MAPK8—Alzheimer's disease	2.94e-05	0.000104	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	2.89e-05	0.000102	CbGpPWpGaD
Boceprevir—CTSL—Immune System—AKT1—Alzheimer's disease	2.88e-05	0.000102	CbGpPWpGaD
Boceprevir—CTSV—Immune System—AKT1—Alzheimer's disease	2.88e-05	0.000102	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	2.87e-05	0.000102	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	2.82e-05	9.97e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ND1—Alzheimer's disease	2.77e-05	9.82e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—VEGFA—Alzheimer's disease	2.71e-05	9.59e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	2.68e-05	9.48e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	2.65e-05	9.39e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—IL6—Alzheimer's disease	2.58e-05	9.15e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TGFB1—Alzheimer's disease	2.49e-05	8.81e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	2.49e-05	8.8e-05	CbGpPWpGaD
Boceprevir—CTSK—Immune System—AKT1—Alzheimer's disease	2.38e-05	8.44e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—TPI1—Alzheimer's disease	2.37e-05	8.39e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CHAT—Alzheimer's disease	2.37e-05	8.39e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	2.28e-05	8.08e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MAOB—Alzheimer's disease	2.27e-05	8.04e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CA4—Alzheimer's disease	2.26e-05	7.98e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—GAPDH—Alzheimer's disease	2.19e-05	7.74e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—IL6—Alzheimer's disease	2.13e-05	7.53e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	2.12e-05	7.51e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—A2M—Alzheimer's disease	2.11e-05	7.47e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	2.11e-05	7.46e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—TP53—Alzheimer's disease	2.05e-05	7.25e-05	CbGpPWpGaD
Boceprevir—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.02e-05	7.16e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	2.01e-05	7.12e-05	CbGpPWpGaD
Boceprevir—CTSS—Immune System—AKT1—Alzheimer's disease	1.96e-05	6.95e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.94e-05	6.85e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.92e-05	6.79e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—IL6—Alzheimer's disease	1.87e-05	6.64e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.84e-05	6.51e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ACHE—Alzheimer's disease	1.84e-05	6.5e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—INPP5D—Alzheimer's disease	1.82e-05	6.43e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.81e-05	6.4e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.79e-05	6.33e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.79e-05	6.33e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.77e-05	6.26e-05	CbGpPWpGaD
Boceprevir—CMA1—Signaling Pathways—AKT1—Alzheimer's disease	1.73e-05	6.12e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	1.72e-05	6.09e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ENO1—Alzheimer's disease	1.72e-05	6.09e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.71e-05	6.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.71e-05	6.05e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	1.69e-05	5.98e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.65e-05	5.84e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—BCHE—Alzheimer's disease	1.6e-05	5.66e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—A2M—Alzheimer's disease	1.59e-05	5.64e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	1.59e-05	5.64e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	1.51e-05	5.35e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	1.46e-05	5.18e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ACHE—Alzheimer's disease	1.39e-05	4.91e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—INPP5D—Alzheimer's disease	1.37e-05	4.85e-05	CbGpPWpGaD
Boceprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.35e-05	4.76e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ENO1—Alzheimer's disease	1.3e-05	4.6e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS1—Alzheimer's disease	1.3e-05	4.6e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	1.27e-05	4.51e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	1.26e-05	4.47e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	1.26e-05	4.45e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—BCHE—Alzheimer's disease	1.21e-05	4.27e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—LPL—Alzheimer's disease	1.15e-05	4.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PLCB1—Alzheimer's disease	1.14e-05	4.03e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—ABCA1—Alzheimer's disease	1.1e-05	3.91e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CHAT—Alzheimer's disease	1.1e-05	3.9e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—TPI1—Alzheimer's disease	1.1e-05	3.9e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.06e-05	3.74e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	1.03e-05	3.66e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.02e-05	3.6e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—A2M—Alzheimer's disease	9.82e-06	3.48e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CALM1—Alzheimer's disease	9.66e-06	3.42e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—APOE—Alzheimer's disease	9.63e-06	3.41e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—CAV1—Alzheimer's disease	9.54e-06	3.38e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	9.52e-06	3.37e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—HMOX1—Alzheimer's disease	9.48e-06	3.35e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—LPL—Alzheimer's disease	8.67e-06	3.07e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ACHE—Alzheimer's disease	8.54e-06	3.02e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	8.44e-06	2.99e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PPARG—Alzheimer's disease	8.39e-06	2.97e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—INS—Alzheimer's disease	8.23e-06	2.91e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ENO1—Alzheimer's disease	8e-06	2.83e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	8e-06	2.83e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	7.85e-06	2.78e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—MTHFR—Alzheimer's disease	7.8e-06	2.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—BCHE—Alzheimer's disease	7.44e-06	2.63e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CALM1—Alzheimer's disease	7.29e-06	2.58e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—APOE—Alzheimer's disease	7.27e-06	2.57e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—NOS3—Alzheimer's disease	7.21e-06	2.55e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—CAV1—Alzheimer's disease	7.2e-06	2.55e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	7.02e-06	2.49e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	6.81e-06	2.41e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	6.6e-06	2.34e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PPARG—Alzheimer's disease	6.33e-06	2.24e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—INS—Alzheimer's disease	6.21e-06	2.2e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	5.87e-06	2.08e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	5.84e-06	2.07e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—NOS3—Alzheimer's disease	5.44e-06	1.93e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—LPL—Alzheimer's disease	5.34e-06	1.89e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—PTGS2—Alzheimer's disease	4.98e-06	1.76e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	4.81e-06	1.7e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CALM1—Alzheimer's disease	4.49e-06	1.59e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—APOE—Alzheimer's disease	4.48e-06	1.58e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—CAV1—Alzheimer's disease	4.44e-06	1.57e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PPARG—Alzheimer's disease	3.9e-06	1.38e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—INS—Alzheimer's disease	3.82e-06	1.35e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—NOS3—Alzheimer's disease	3.35e-06	1.19e-05	CbGpPWpGaD
Boceprevir—CYP3A5—Metabolism—AKT1—Alzheimer's disease	3.32e-06	1.17e-05	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	3.07e-06	1.09e-05	CbGpPWpGaD
Boceprevir—ABCB1—Metabolism—AKT1—Alzheimer's disease	2.5e-06	8.86e-06	CbGpPWpGaD
Boceprevir—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.54e-06	5.46e-06	CbGpPWpGaD
